PHARMAC responds on long-acting insulin analogues.
Metcalfe
Scott
S
Evans
Jackie
J
Moodie
Peter
P
D003362:Cost-Benefit Analysis; D003920:Diabetes Mellitus / Q000188:drug therapy*; D017277:Drug Approval / Q000191:economics*; D015276:Health Care Rationing / Q000191:economics; D006801:Humans; D049528:Insulin, Long-Acting / Q000031:analogs & derivatives*; D009313:National Health Programs / Q000191:economics; D009520:New Zealand
D049528:Insulin, Long-Acting